Cost optimization Pharmaceutical Strategies Group (PSG) has a proven track record of delivering over $7 billion in savings for healthcare clients across 20 million lives, indicating a strong value proposition for expanding cost-management and negotiation services with prospective health systems, payers, and large employers.

Specialty drug focus PSG highlights a growing emphasis on specialty drug benefits and evolving payer coverage strategies, suggesting opportunities to offer targeted specialty drug benefit design, trend analyses, and coverage optimization for clients navigating high-cost therapies.

Strategic partnerships As an acquisition by Omnicell and ongoing collaboration with EPIC platforms, PSG presents prospects for integrated solutions that combine pharmacology data, procurement analytics, and technology-enabled services within hospital systems, health plans, and multi-employer programs.

Analytics leadership With a data-driven approach and analytics-powered insights, PSG can upsell advanced analytics, procurement strategy, and revenue optimization services to clients seeking independent, unbiased pharmacy intelligence to improve ROI.

Expansion signals Recent leadership appointments and annual reports on drug benefit design indicate momentum in scaling operations and thought leadership, offering cross-sell opportunities for consulting engagements, market trend reports, and advisory services to new and existing clients.